Summary
This 8-K filing from Cardinal Health, Inc. (CAH) announces a significant leadership change in its financial operations. Effective November 11, 2014, Michael C. Kaufmann will assume the role of Chief Financial Officer (CFO). Mr. Kaufmann brings extensive experience to this critical position, having served as Chief Executive Officer of the Pharmaceutical Segment since August 2009. This transition is part of a planned succession, as the current CFO, Jeffrey W. Henderson, is retiring in August 2015 and will remain with the company until then to ensure a smooth handover. Investors should note the compensation package for the incoming CFO, which includes a base salary of $700,000 and a substantial restricted share unit grant valued at $3 million, vesting over three years. This indicates a strong commitment to retaining and incentivizing key financial leadership. Additionally, Jon L. Giacomin, currently President of U.S. Pharmaceutical Distribution, will succeed Mr. Kaufmann as CEO of the Pharmaceutical Segment, signaling continuity in operational leadership as well.
Key Highlights
- 1Michael C. Kaufmann appointed Chief Financial Officer (CFO) effective November 11, 2014.
- 2Kaufmann's compensation includes a $700,000 base salary.
- 3Kaufmann will receive a $3 million restricted share unit grant, vesting over three years.
- 4Current CFO, Jeffrey W. Henderson, is retiring in August 2015 and will assist in the transition.
- 5Jon L. Giacomin appointed Chief Executive Officer, Pharmaceutical Segment.
- 6The appointment reflects a planned succession in key financial and operational leadership roles.